Your browser doesn't support javascript.
loading
Underrecognition and Suboptimal Quality of Care for Nonalcoholic Fatty Liver Disease Cirrhosis in Primary Care Patients with Diabetes Mellitus.
Chu, Janet N; Goldman, Max L; Brandman, Danielle; Sohn, Jae Ho; Islam, Kendall; Ross, Lauren A; Fox, Rena K.
Afiliação
  • Chu JN; Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA.
  • Goldman ML; Division of Hospital Medicine, Department of Medicine, San Francisco Veterans Affairs Medical Center and University of California, San Francisco, CA; Department of Gastroenterology, Kaiser Permanente San Francisco, CA.
  • Brandman D; Center for Liver Disease and Transplantation, Weill Cornell Medicine, New York, NY.
  • Sohn JH; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA.
  • Islam K; School of Medicine, University of California, San Francisco, CA.
  • Ross LA; Department of Psychological and Brain Sciences, Dartmouth College, Hanover, NH.
  • Fox RK; Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, CA. Electronic address: rena.fox@ucsf.edu.
Am J Med ; 137(2): 172-177.e2, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37890572
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a leading cause of cirrhosis but is underrecognized in primary care. Cirrhosis management requires complex monitoring, and the quality of care (QoC) for NAFLD cirrhosis patients in primary care may be inadequate. METHODS: In this retrospective-prospective cohort study of primary care patients with diabetes mellitus, we identified patients with NAFLD cirrhosis by 1) evidence of cirrhosis from abdominal imaging identified by natural language processing, or 2) existence of International Classification of Diseases code for cirrhosis. A finding of either was followed by manual chart review for confirmation of both cirrhosis and NAFLD. We then determined if cirrhosis care measures were up-to-date, including hepatitis A and B vaccination, Model for End-Stage Liver Disease score components, esophagogastroduodenoscopy, and hepatocellular carcinoma screening. We created a composite score quantifying overall QoC (scale 0-8), with high QoC defined as ≥6 points. RESULTS: Among 3,028 primary care patients with diabetes mellitus, we identified 51 (1.7%) with NAFLD cirrhosis. Although 78% had ≥3 average primary care visits/year, only 24% completed hepatocellular carcinoma screening at least annually in at least 75% of years since diagnosis. The average QoC composite score was 4.9 (SD 2.4), and less than one-third had high QoC. CONCLUSIONS: NAFLD cirrhosis is prevalent but underdiagnosed in primary care, and receipt of comprehensive QoC was suboptimal. Given the rising incidence of NAFLD cirrhosis, primary care providers need improved awareness and mechanisms to ensure high QoC for this population.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus / Doença Hepática Terminal / Hepatopatia Gordurosa não Alcoólica / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Am J Med Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Diabetes Mellitus / Doença Hepática Terminal / Hepatopatia Gordurosa não Alcoólica / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Am J Med Ano de publicação: 2024 Tipo de documento: Article